Document Type

Article

Department/Program

General Education

Journal Title

Radiotherapy and Oncology

Pub Date

5-8-2014

Volume

111

Issue

3

Journal Article URL

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119546/

First Page

468

Abstract

Glioblastoma multiforme (GBM) represents the most common and deadly primary brain malignancy, particularly due to temozolomide (TMZ) and radiation (RT) resistance. To better understand resistance mechanisms, we examined global kinase activity (kinomic profiling) in both treatment sensitive and resistant human GBM patient-derived xenografts (PDX or “xenolines”).

DOI

https://doi.org/10.1016/j.radonc.2014.04.010

Publisher Statement

Radiother Oncol. Author manuscript; available in PMC 2015 Jun 1. Published in final edited form as: Radiother Oncol. 2014 Jun; 111(3): 468–474. Published online 2014 May 8. doi: 10.1016/j.radonc.2014.04.010

Share

COinS